Skip to content

A Randomized Incentive-Based Weight Loss Trial in Singapore

A Randomized Incentive-Based Weight Loss Trial in Singapore

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01533454
Enrollment
161
Registered
2012-02-15
Start date
2012-09-30
Completion date
2015-10-31
Last updated
2016-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incentives, Obesity

Keywords

Obesity, Weight loss, Incentives, Motivation

Brief summary

The purpose of this study is to test the extent to which incentives, when combined with an existing evidence-based weight loss program, improve weight loss and weight loss maintenance. It will also compare the cost-effectiveness of the incentive-based weight loss programs to the basic program without incentives.

Detailed description

Globally, the rise in obesity rates has reached epidemic proportions, and in Singapore 53% of adults have a body mass index (BMI) great than 23.0 kg/m2, a level that increases risk for chronic disease among Asians. This study aims to test the extent to which traditional or behavioural economic incentives, when combined with an existing evidence-based weight loss program, improve weight loss and weight loss maintenance. Data will be collected through a two-arm (basic weight loss program, basic program plus traditional or behavioural economic incentives) randomized controlled trial (RCT) where key outcome variables are defined as weight loss (kilograms) at 8 months when the incentive program concludes, and at 12 months, after a 4 month period in which no additional incentives are provided. We hypothesize that at both 8 and 12 months, weight loss will be greater in the incentive arm than in the arm without incentives. The growing obesity epidemic, the high costs of obesity to employers, insurers and governments across Asia, and the fact that the incentive program is designed to be close to cost neutral, suggest that this research has high potential to have a significant public health impact, both in Singapore and the region.

Interventions

OTHERFinancial Incentives

Incentive arm participants will be able to earn incentives for meeting specified weight loss targets or step goals. They will be offered a choice between traditional (payments with certainty) and behavioral(payments paid via lottery) incentives.

Sponsors

Singapore General Hospital
CollaboratorOTHER
Duke-NUS Graduate Medical School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Signed informed consent * Age 21+ * BMI 25+ * Willing to be randomized into 1 of the 2 study arms * Willing to pay the $399 entry fee * Stated willingness to commit to participating in all assessments regardless of weight change or study arm

Exclusion criteria

* Current pregnancy/lactation (women who become pregnant during the study will be withdrawn) * Type 1 diabetes * Type 2 diabetes on medication other than Metformin * End-stage Renal Disease * Ischemic Heart Disease requiring intervention in the past 6 months * Thyroid disease that has yet to stabilize * Changes in weight of greater than 3% in the past 6 months * Use of weight loss medication in the past 6 months * Malignancy requiring chemotherapy/radiation in the past 5 years * Acute medical problems requiring 3+ days of missed work during previous 4 week period * Any serious hospitalization or surgery in the past 6 months * Use of corticosteroids in the past 6 months * Answer 'YES' to any of the PAR-Q questions * Unable to obtain MD consent from a physician giving permission to participate in the study * Evidence of clinical depression (as assessed by the Beck Depression Inventory) * Currently on medications for a mental health or substance abuse condition * Evidence of binge eating based on the Binge Eating Disorders Scale (BEDS) * Unable to communicate in English * Additional concerns in which the clinical investigator deems problematic for participation

Design outcomes

Primary

MeasureTime frame
Weight changeBaseline, 4 months, 8 months and 12 months

Secondary

MeasureTime frame
Self-reported physical activityBaseline, 4 months, 8 months, 12 months
Steps, aerobic steps and minutes of physical activityMonthly through month 8 (in incentive arms)
Intrinsic and Extrinsic motivationBaseline
Percent body fatBaseline, 4 months, 8 months, 12 months
Health-related quality of lifeBaseline, 4 months, 8 months, 12 months
Intervention costsBaseline through month 8
SociodemographicsBaseline

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026